{"name":"Jakob Møller Hansen, MD.","slug":"jakob-m-ller-hansen-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Betamethasone and local anesthetic","genericName":"Betamethasone and local anesthetic","slug":"betamethasone-and-local-anesthetic","indication":"Inflammatory skin conditions with associated pain","status":"marketed"}]}],"pipeline":[{"name":"Betamethasone and local anesthetic","genericName":"Betamethasone and local anesthetic","slug":"betamethasone-and-local-anesthetic","phase":"marketed","mechanism":"Betamethasone reduces inflammation and immune response while the local anesthetic component provides pain relief at the site of administration.","indications":["Inflammatory skin conditions with associated pain","Localized musculoskeletal inflammation and pain","Intra-articular or periarticular injection for joint inflammation"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE5kYmdkdHVqMHM0YVNWU3NRVU03Qi1zMzVwalEtSTcxOVlOd2FndFZ2Q1lEUUpocUFxalZnWHFZeXVQSUxWT1ZTcVNyN25qYkx5SjdwVTNLRFNaN2VGZWMyRmgycUtZS19rRHc?oc=5","date":"2023-12-08","type":"pipeline","source":"Neurology® Journals","summary":"Reduced efficacy of sumatriptan in migraine with aura vs without aura - Neurology® Journals","headline":"Reduced efficacy of sumatriptan in migraine with aura vs without aura - Neurology® Journals","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}